SCHEMBL24239107

SCHEMBL24239107

c1cc(-c2nc(-c3cccc4ccccc34)nc(-c3cccc4oc5cc(-c6cccc7ccccc67)ccc5c34)n2)cc(-c2cccc3c2sc2c4ccccc4ccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 5/20 0.36
▸ CYP1B1 Q16678 5/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ CYP1A2 P05177 4/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MAP1LC3B Q9GZQ8 1/20 0.33
▸ MAP1LC3A Q9H492 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ ATM Q13315 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23819375 0.94 CYP1A1 (0.39) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL21425166 0.91 PRKDC (0.45) PRKDCCYP1A2TDP1L3MBTL1MAP1LC3B
SCHEMBL25132186 0.90 CYP1A1 (0.35) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL24239164 0.89 CYP1A1 (0.35) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL22247884 0.88 PRKDC (0.43) PRKDCTDP1L3MBTL1MAP1LC3BMAP1LC3A
SCHEMBL21261187 0.87 PRKDC (0.38) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL24239161 0.87 CYP1A1 (0.36) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL22880069 0.86 TDP1 (0.38) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL25132286 0.86 CYP1A1 (0.33) CYP1A1CYP1B1PRKDCCYP1A2TDP1
SCHEMBL25459159 0.86 PRKDC (0.38) PRKDCTDP1L3MBTL1ALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 — — US disclosed
US-20220037594-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 CYP1A1 897/4885CYP1B1 2461/4885PRKDC 2965/4885
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof PIEZO1, ORAI2, OCIAD1 CYP1A1 787/4885CYP1B1 1728/4885PRKDC 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback